You Should Know These Things About Spectrum Pharmaceuticals Inc. (SPPI)

As of Friday close, Spectrum Pharmaceuticals Inc.’s (NASDAQ:SPPI) stock was up $0.02, moving up 3.19 percent to $0.77. The average number of shares traded per day over the past five days has been 2,393,980 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.0756 fall in that time frame. In the last twenty days, the average volume was 2,107,475, while in the previous 50 days, it was 2,550,800.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Since last month, SPPI stock retreated -24.86%. Shares of the company fell to $0.6902 on 05/12/22, the lowest level in the past month. A 52-week high of $4.54 was reached on 01/03/22 after having rallying from a 52-week low of $0.60. Since the beginning of this year, SPPI’s stock price has dropped by -39.06% or -$0.4961, and marked a new high 1 time. However, the stock has declined by -82.95% since its 52-week high.

Spectrum Pharmaceuticals Inc. (SPPI) last reported insider trading activity 39 days ago on Apr 05. LEBEL FRANCOIS, the Chief Medical Officer of the company, disposed of 1,367 shares for $1.41 on Apr 05. It resulted in a $1,927 divestment by the insider. LEBEL FRANCOIS sold 1,205 shares at an average price of $1.35 on Apr 04. The insider now owns 253,880 shares following the transaction. On Mar 16, Chief Legal Officer McGahan Keith M sold 16,318 shares at $0.71 apiece. The transaction was valued at $11,521.

Financial Health

In the three months ended March 30, Spectrum Pharmaceuticals Inc.’s quick ratio stood at 2.00, while its current ratio was 2.00, showing that the company is able to pay off its debt.

According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. While analysts expected Spectrum Pharmaceuticals Inc. to report -$0.19 quarterly earnings, the actual figure was -$0.08 per share, beating the consensus estimate by 57.90%. During the quarter, the company generated -$36.78 million in EBITDA. The liabilities of Spectrum Pharmaceuticals Inc. were 63.99 million at the end of its most recent quarter ended March 30, and its total debt was $2.73 million. The value of shareholders’ equity is $177.15 million.

Technical Picture

This quick technical analysis looks at Spectrum Pharmaceuticals Inc.’s (SPPI) price momentum. With a historical volatility rate of 87.41%, the RSI 9-day stood at 36.00% on 13 May.

With respect to its five-day moving average, the current Spectrum Pharmaceuticals Inc. price is down by -8.90% percent or -$0.0756. At present, SPPI shares trade -20.22% below its 20-day simple moving average and -49.09% percent below its 100-day simple moving average. However, the stock is currently trading approximately +6.01% above its SMA50 and -75.97% below its SMA200.

Stochastic coefficient K was 19.13% and Stochastic coefficient D was 15.39%, while ATR was 0.0927. Given the Stochastic reading of 31.03% for the 14-day period, the RSI (14) reading has been calculated as 38.26%. As of today, the MACD Oscillator reading stands at -0.0693, while the 14-day reading stands at -0.0853.

Analyst Ratings

JMP Securities launched its rating on Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) to a Mkt outperform in a note to investors on September 17, 2020. Spectrum Pharmaceuticals Inc. (SPPI) has been rated Buy by analysts. According to 0 brokerage firms , SPPI is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Spectrum Pharmaceuticals Inc. stock as buy, with 4 recommending it as overweight.

With a median target price of $4.00, the current consensus forecast for the stock is $3.00 – $10.00. Based on these forecasts, analysts predict Spectrum Pharmaceuticals Inc. (SPPI) will achieve an average price target of $5.60.


Please enter your comment!
Please enter your name here

Hot Topics

Related Articles